FUSN Insider Trading

Insider Ownership Percentage: 7.75%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Fusion Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Fusion Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fusion Pharmaceuticals Share Price & Price History

Current Price: $21.32
Price Change: Price Increase of +0.02 (0.09%)
As of 03/28/2024 01:00 AM ET

This chart shows the closing price history over time for FUSN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Fusion Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2022Steven GannonDirectorBuy44,400$2.03$90,132.0056,400View SEC Filing Icon  
4/27/2022John ValliantCEOSell4,511$6.03$27,201.33318,147View SEC Filing Icon  
4/25/2022John ValliantCEOSell2,036$6.03$12,277.08324,805View SEC Filing Icon  
4/20/2022John ValliantCEOSell367$6.02$2,209.34327,763View SEC Filing Icon  
4/13/2022John ValliantCEOSell11,994$6.41$76,881.54328,130View SEC Filing Icon  
4/11/2022John ValliantCEOSell2,600$7.37$19,162.00358,379View SEC Filing Icon  
4/8/2022John ValliantCEOSell826$7.52$6,211.52360,979View SEC Filing Icon  
4/6/2022John ValliantCEOSell100$7.58$758.00360,979View SEC Filing Icon  
3/30/2022John ValliantCEOSell300$7.52$2,256.00View SEC Filing Icon  
3/28/2022John ValliantCEOSell9,600$7.55$72,480.00View SEC Filing Icon  
3/25/2022John ValliantCEOSell500$7.42$3,710.00View SEC Filing Icon  
3/23/2022John ValliantCEOSell100$7.50$750.00View SEC Filing Icon  
3/21/2022John ValliantCEOSell1,500$7.47$11,205.00View SEC Filing Icon  
3/17/2022John ValliantCEOSell900$7.51$6,759.00View SEC Filing Icon  
3/7/2022John ValliantCEOSell3,100$6.99$21,669.00View SEC Filing Icon  
3/4/2022John ValliantCEOSell8,400$7.32$61,488.00View SEC Filing Icon  
2/28/2022John ValliantCEOSell3,100$7.40$22,940.00View SEC Filing Icon  
2/24/2022John ValliantCEOSell2,500$7.41$18,525.00View SEC Filing Icon  
2/22/2022John ValliantCEOSell4,100$7.85$32,185.00View SEC Filing Icon  
2/17/2022John ValliantCEOSell1,700$7.98$13,566.00View SEC Filing Icon  
2/15/2022John ValliantCEOSell12,600$8.33$104,958.00View SEC Filing Icon  
8/23/2021Steven GannonDirectorBuy2,829$7.99$22,603.7112,000View SEC Filing Icon  
8/16/2021Steven GannonDirectorBuy6,000$8.10$48,600.006,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Fusion Pharmaceuticals (NASDAQ:FUSN)

72.85% of Fusion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FUSN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Fusion Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/5/2024Wellington Management Group LLP744,474$7.15M0.0%N/A1.028%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.15,132$0.15M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/15/2024Chartwell Investment Partners LLC49,890$0.48M0.0%N/A0.069%Search for SEC Filing on Google Icon
2/15/2024Pier Capital LLC277,111$2.66M0.4%N/A0.383%Search for SEC Filing on Google Icon
2/15/2024Sphera Funds Management LTD.1,085,639$10.43M1.7%-19.8%1.499%Search for SEC Filing on Google Icon
2/15/2024Weiss Multi Strategy Advisers LLC172,357$1.66M0.0%N/A0.238%Search for SEC Filing on Google Icon
2/15/2024Forefront Analytics LLC16,715$0.16M0.1%-50.4%0.023%Search for SEC Filing on Google Icon
2/14/2024Royal Bank of Canada34,519$0.33M0.0%+721.1%0.048%Search for SEC Filing on Google Icon
2/14/2024Point72 Asset Management L.P.293,611$2.82M0.0%-10.7%0.406%Search for SEC Filing on Google Icon
2/14/2024Cubist Systematic Strategies LLC67,470$0.65M0.0%+674,600.0%0.093%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP6,500,328$62.47M2.3%+12.4%8.978%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP45,801$0.44M0.3%N/A0.063%Search for SEC Filing on Google Icon
2/14/2024Verition Fund Management LLC109,386$1.05M0.0%N/A0.151%Search for SEC Filing on Google Icon
2/14/2024Privium Fund Management B.V.141,750$1.36M0.3%N/A0.196%Search for SEC Filing on Google Icon
2/13/2024Envestnet Asset Management Inc.11,454$0.11M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 3,008$29K0.0%+2,064.0%0.004%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.15,132$0.15M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC30,939$0.30M0.0%+76.9%0.043%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG223,092$2.14M0.0%+139.1%0.308%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC86,199$0.83M0.0%N/A0.119%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund6,630$64K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/1/2024Jennison Associates LLC301,020$2.89M0.0%N/A0.416%Search for SEC Filing on Google Icon
2/1/2024Signaturefd LLC2,949$28K0.0%+883.0%0.004%Search for SEC Filing on Google Icon
1/31/2024abrdn plc21,697$0.21M0.0%N/A0.030%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.10,886,153$104.62M0.3%+1.9%15.034%Search for SEC Filing on Google Icon
1/30/2024HealthInvest Partners AB125,000$1.20M0.9%N/A0.173%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.8,376$80K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/16/2024Raymond James Financial Services Advisors Inc.31,145$0.30M0.0%N/A0.043%Search for SEC Filing on Google Icon
1/12/2024Yarbrough Capital LLC76,872$0.74M0.0%N/A0.106%Search for SEC Filing on Google Icon
11/14/2023Avidity Partners Management LP5,781,850$15.03M0.6%+1.4%7.985%Search for SEC Filing on Google Icon
11/13/2023Federated Hermes Inc.10,683,789$27.78M0.1%+0.5%14.755%Search for SEC Filing on Google Icon
11/13/2023FMR LLC4,177,848$10.86M0.0%-10.8%5.770%Search for SEC Filing on Google Icon
11/8/2023Forefront Analytics LLC33,685$88K0.0%+67.8%0.049%Search for SEC Filing on Google Icon
10/27/2023Eagle Health Investments LP579,769$1.51M0.3%-14.8%0.840%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC2,751,395$12.85M0.4%-0.3%3.988%Search for SEC Filing on Google Icon
8/15/2023Sphera Funds Management LTD.1,329,258$6.21M1.0%+3.6%1.926%Search for SEC Filing on Google Icon
8/14/2023Eagle Health Investments LP680,370$3.18M0.6%N/A0.986%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC30,374$0.14M0.0%+20.8%0.044%Search for SEC Filing on Google Icon
8/11/2023Artal Group S.A.1,725,000$8.06M0.2%-12.7%2.500%Search for SEC Filing on Google Icon
5/16/2023Perceptive Advisors LLC2,759,936$10.41M0.3%N/A4.367%Search for SEC Filing on Google Icon
5/16/2023Sphera Funds Management LTD.1,283,537$4.84M0.8%N/A2.031%Search for SEC Filing on Google Icon
5/15/2023Schonfeld Strategic Advisors LLC13,100$49K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP35,900$0.14M0.0%N/A0.057%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP44,827$0.17M0.0%N/A0.071%Search for SEC Filing on Google Icon
5/15/2023Ghost Tree Capital LLC350,000$1.32M0.4%N/A0.554%Search for SEC Filing on Google Icon
5/15/2023Sio Capital Management LLC246,036$0.93M0.5%-5.5%0.389%Search for SEC Filing on Google Icon
5/12/2023UBS Group AG89,786$0.34M0.0%+43.3%0.142%Search for SEC Filing on Google Icon
5/11/2023FMR LLC4,681,457$17.65M0.0%+73.9%7.406%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.5,849,100$22.05M0.1%+81.4%9.253%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC13,084$49K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley107,948$0.34M0.0%+40.8%0.241%Search for SEC Filing on Google Icon
2/15/2023Braidwell LP2,000,000$6.30M0.2%N/A4.468%Search for SEC Filing on Google Icon
2/14/2023Point72 Asset Management L.P.328,868$1.04M0.0%+6.1%0.735%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC23,500$74K0.0%+39.9%0.053%Search for SEC Filing on Google Icon
2/10/2023Tekla Capital Management LLC43,394$0.14M0.0%-57.4%0.097%Search for SEC Filing on Google Icon
2/8/2023UBS Group AG62,676$0.20M0.0%+14.2%0.140%Search for SEC Filing on Google Icon
11/15/2022Federated Hermes Inc.3,174,100$9.56M0.0%+1.6%7.091%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC28,494$86K0.0%N/A0.064%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.310,068$0.93M0.0%-5.7%0.693%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC16,800$51K0.0%N/A0.038%Search for SEC Filing on Google Icon
11/14/2022RA Capital Management L.P.659,992$1.99M0.0%N/A1.474%Search for SEC Filing on Google Icon
11/14/2022UBS Oconnor LLC17,286$52K0.0%N/A0.039%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG54,904$0.17M0.0%+167.1%0.127%Search for SEC Filing on Google Icon
11/8/2022Sofinnova Investments Inc.117,099$0.35M0.0%+50.0%0.270%Search for SEC Filing on Google Icon
11/4/2022Prudential Financial Inc.14,600$44K0.0%N/A0.034%Search for SEC Filing on Google Icon
11/2/2022Victory Capital Management Inc.50,390$0.15M0.0%-72.2%0.116%Search for SEC Filing on Google Icon
11/1/2022Tekla Capital Management LLC101,931$0.61M0.0%+134.9%0.235%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.3,124,100$7.78M0.0%+2.3%7.200%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.328,868$0.82M0.0%-6.0%0.758%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC11,722$29K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/15/2022Pivotal bioVenture Partners Investment Advisor LLC1,560,982$3.89M2.0%-2.3%3.597%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP25,703$0.20M0.0%-89.4%0.059%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG21,300$0.17M0.0%+45,219.1%0.049%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.3,055,037$23.74M0.1%+94.1%7.049%Search for SEC Filing on Google Icon
5/4/2022Victory Capital Management Inc.183,690$1.30M0.0%-26.6%0.424%Search for SEC Filing on Google Icon
2/25/2022AlphaCentric Advisors LLC100,000$0.42M0.1%N/A0.232%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC1,227,017$5.12M0.1%-2.2%2.849%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.1,048,956$4.37M0.0%+22.3%2.436%Search for SEC Filing on Google Icon
2/7/2022Victory Capital Management Inc.250,380$1.04M0.0%-6.5%0.581%Search for SEC Filing on Google Icon
12/3/2021Perceptive Advisors LLC1,254,607$9.94M0.1%-29.3%2.913%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.858,012$6.80M0.0%-2.0%1.992%Search for SEC Filing on Google Icon
11/15/2021Sectoral Asset Management Inc38,198$0.30M0.0%N/A0.089%Search for SEC Filing on Google Icon
11/12/2021Johnson & Johnson3,670,516$29.07M2.6%N/A8.523%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.414,256$3.28M0.0%-11.9%0.963%Search for SEC Filing on Google Icon
11/2/2021Victory Capital Management Inc.267,703$2.12M0.0%-0.7%0.622%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP154,597$1.25M0.0%+24.1%0.364%Search for SEC Filing on Google Icon
8/17/2021Perceptive Advisors LLC1,775,167$14.34M0.2%-9.0%4.181%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.875,141$7.07M0.0%+16.7%2.061%Search for SEC Filing on Google Icon
8/16/2021Perceptive Advisors LLC1,775,167$14.34M0.2%-9.0%4.181%Search for SEC Filing on Google Icon
8/16/2021Federated Hermes Inc.597,841$4.83M0.0%+5.8%1.408%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.18,221$0.15M0.0%+29.5%0.043%Search for SEC Filing on Google Icon
8/13/2021Adams Street Partners LLC2,973,744$24.03M5.0%-0.5%7.004%Search for SEC Filing on Google Icon
8/13/2021FMR LLC3,184,209$25.73M0.0%+1.5%7.500%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.470,303$3.80M0.0%-41.8%1.108%Search for SEC Filing on Google Icon
8/3/2021Victory Capital Management Inc.269,623$2.18M0.0%-5.6%0.635%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC10,726$0.12M0.0%-76.9%0.025%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.750,000$8.04M0.0%+36.4%1.766%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley76,171$0.82M0.0%+90.7%0.179%Search for SEC Filing on Google Icon
5/17/2021Perceptive Advisors LLC1,950,167$20.91M0.3%-12.8%4.593%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP124,594$1.34M0.0%+135.9%0.293%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Fusion Pharmaceuticals logo
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines in Canada and the United States. The company's lead product candidates include FPI-2265 that is in Phase 2 clinical trial to treat prostate-specific membrane antigens; and FPI-1434 that is in Phase 1 clinical trial as a monotherapy in patients with solid tumors expressing that target insulin-like growth factor 1 receptor. It also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, the company develops FPI-1966 for the treatment of multiple cancers, including colorectal, ovarian, bladder, and head and neck cancers.; FPI-2068, a bispecific antibody, which is in Phase 1 clinical trial targeting epidermal growth factor receptor, and mesenchymal epithelial transition factor. It has a strategic collaboration agreement with AstraZeneca UK Limited to discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.
Read More on Fusion Pharmaceuticals

Today's Range

Now: $21.32
Low: $21.25
High: $21.37

50 Day Range

MA: $12.70
Low: $9.12
High: $21.32

52 Week Range

Now: $21.32
Low: $2.31
High: $21.44

Volume

1,564,293 shs

Average Volume

4,111,024 shs

Market Capitalization

$1.81 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Fusion Pharmaceuticals?

Fusion Pharmaceuticals' top insider shareholders include:
  1. John Valliant (CEO)
  2. Steven Gannon (Director)
Learn More about top insider investors at Fusion Pharmaceuticals.

Who are the major institutional investors of Fusion Pharmaceuticals?

Fusion Pharmaceuticals' top institutional investors include:
  1. Federated Hermes Inc. — 15.03%
  2. Avidity Partners Management LP — 8.98%
  3. Sphera Funds Management LTD. — 1.50%
  4. Wellington Management Group LLP — 1.03%
  5. Jennison Associates LLC — 0.42%
  6. Point72 Asset Management L.P. — 0.41%
Learn More about top institutional investors of Fusion Pharmaceuticals stock.

Which institutional investors are selling Fusion Pharmaceuticals stock?

In the previous quarter, FUSN stock was sold by these institutional investors:
  1. Sphera Funds Management LTD.
  2. Point72 Asset Management L.P.
  3. Forefront Analytics LLC

Which institutional investors are buying Fusion Pharmaceuticals stock?

During the last quarter, FUSN stock was acquired by institutional investors including:
  1. Wellington Management Group LLP
  2. Avidity Partners Management LP
  3. Jennison Associates LLC
  4. Pier Capital LLC
  5. Federated Hermes Inc.
  6. Weiss Multi Strategy Advisers LLC
  7. Privium Fund Management B.V.
  8. UBS Group AG